A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1

Molecular Brain

Volumn 3, Issue 1, 2010, Pages

  Fitzjohn, Stephen M ^a   Kuenzi, Frederick ^a,b   Morton, Robin A ^a,b   Rosahl, Thomas W ^b,c   Lewis, Huw ^b   Smith, David ^b   Seabrook, Guy R ^b,d   Collingridge, Graham L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; KYNURENIC ACID; MUTANT PROTEIN; PRESENILIN 1;

AGE DISTRIBUTION; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; BRAIN SLICE; FACILITATION; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE; WILD TYPE; AGING; AMYLOID PLAQUE; ANIMAL; ELECTROSTIMULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; HIPPOCAMPAL CA1 REGION; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TETANY;

ANIMALIA; MUS MUSCULUS;

AGING; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CA1 REGION, HIPPOCAMPAL; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; LONG-TERM POTENTIATION; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; PLAQUE, AMYLOID; PRESENILIN-1; SYNAPTIC TRANSMISSION; TETANY;

EID: 77954475089     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-3-21     Document Type: Article

References (55)

1. Amyloid, the presenilins and Alzheimer's disease. J Hardy, Trends Neurosci 1997 20 4 154 159 10.1016/S0166-2236(96)01030-2 9106355
2. Mutant genes in familial Alzheimer's disease and transgenic models. DL Price SS Sisodia, Annu Rev Neurosci 1998 21 479 505 10.1146/annurev.neuro.21.1. 479 9530504
3. Alzheimer disease: amyloidogenesis, the presenilins and animal models. M Newman IF Musgrave M Lardelli, Biochimica et biophysica acta 2007 1772 3 285 297 17208417
4. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. M Citron T Oltersdorf C Haass L McConlogue AY Hung P Seubert C Vigo-Pelfrey I Lieberburg DJ Selkoe, Nature 1992 360 6405 672 674 10.1038/360672a0 1465129
5. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. R Sherrington EI Rogaev Y Liang EA Rogaeva G Levesque M Ikeda H Chi C Lin G Li K Holman, et al. Nature 1995 375 6534 754 760 10.1038/375754a0 7596406
6. Presenilin structure, function and role in Alzheimer disease. PE Fraser DS Yang G Yu L Levesque M Nishimura S Arawaka LC Serpell E Rogaeva P St George-Hyslop, Biochimica et biophysica acta 2000 1502 1 1 15 10899427
7. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. M Citron D Westaway W Xia G Carlson T Diehl G Levesque K Johnson-Wood M Lee P Seubert A Davis, et al. Nature medicine 1997 3 1 67 72 10.1038/nm0197-67 8986743
8. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Z Zhang P Nadeau W Song D Donoviel M Yuan A Bernstein BA Yankner, Nat Cell Biol 2000 2 7 463 465 10.1038/35017108 10878814
9. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. K Hsiao P Chapman S Nilsen C Eckman Y Harigaya S Younkin F Yang G Cole, Science (New York, NY) 1996 274 5284 99 102
10. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. MC Irizarry M McNamara K Fedorchak K Hsiao BT Hyman, JNeuropatholExpNeurol 1997 56 9 965 973
11. Microglial response to amyloid plaques in APPsw transgenic mice. SA Frautschy F Yang M Irrizarry B Hyman TC Saido K Hsiao GM Cole, Am J Pathol 1998 152 1 307 317 9422548
12. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. PF Chapman GL White MW Jones D Cooper-Blacketer VJ Marshall M Irizarry L Younkin MA Good TV Bliss BT Hyman, et al. Nature neuroscience 1999 2 3 271 276 10.1038/6374 10195221
13. The use of the hippocampal slice preparation in the study of Alzheimer's disease. SM Fitzjohn AJ Doherty GL Collingridge, European journal of pharmacology 2008 585 50 59 10.1016/j.ejphar.2008.02.077 18423442
14. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. SM Fitzjohn RA Morton F Kuenzi TW Rosahl M Shearman H Lewis D Smith DS Reynolds CH Davies GL Collingridge, et al. Journal of Neuroscience 2001 21 13 4691 4698 11425896
15. Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. JT Brown JC Richardson GL Collingridge AD Randall CH Davies, Hippocampus 2005 15 1 110 117 10.1002/hipo.20036 15390159
16. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. A Parent DJ Linden SS Sisodia DR Borchelt, NeurobiolDis 1999 6 1 56 62 10.1006/nbdi.1998.0207 (Pubitemid 29156468)
17. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. DR Borchelt G Thinakaran CB Eckman MK Lee F Davenport T Ratovitsky CM Prada G Kim S Seekins D Yager, et al. Neuron 1996 17 5 1005 1013 10.1016/S0896-6273(00)80230-5 8938131
18. Alzheimer disease models and human neuropathology: similarities and differences. C Duyckaerts MC Potier B Delatour, Acta Neuropathol 2008 115 1 5 38 10.1007/s00401-007-0312-8 18038275
19. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. F Trinchese S Liu F Battaglia S Walter PM Mathews O Arancio, Annals of neurology 2004 55 6 801 814 10.1002/ana.20101 15174014
20. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. EH Chang MJ Savage DG Flood JM Thomas RB Levy V Mahadomrongkul T Shirao C Aoki PT Huerta, Proceedings of the National Academy of Sciences of the United States of America 2006 103 9 3410 3415 10.1073/pnas.0507313103 16492745
21. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1DeltaE9-deleted transgenic mice model of beta-amyloidosis. A Volianskis R Kostner M Molgaard S Hass MS Jensen, Neurobiology of aging 2010 31 1173 1187 10.1016/j.neurobiolaging.2008.08.005 18790549
22. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. KK Hsiao DR Borchelt K Olson R Johannsdottir C Kitt W Yunis S Xu C Eckman S Younkin D Price, et al. Neuron 1995 15 5 1203 1218 10.1016/0896-6273(95)90107-8 7576662
23. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression. S Qian P Jiang XM Guan G Singh ME Trumbauer H Yu HY Chen LH Van de Ploeg H Zheng, Neuron 1998 20 3 611 617 10.1016/S0896-6273(00)80999-X 9539133
24. Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodiesterase type 6 (PDE6). F Kuenzi TW Rosahl RA Morton SM Fitzjohn GL Collingridge GR Seabrook, Brain Res 2003 967 1-2 144 151 10.1016/S0006-8993(02)04241-5 12650975
25. The mouse gene retinal degeneration (rd) may reduce the number of neurons present in the adult hippocampal dentate gyrus. RE Wimer CC Wimer L Alameddine AJ Cohen, Brain research 1991 547 2 275 278 10.1016/0006-8993(91)90971-W 1884201
26. Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD. HD Lewis D Beher D Smith L Hewson N Cookson DS Reynolds GR Dawson M Jiang LH Van der Ploeg S Qian, et al. Neurobiology of aging 2004 25 9 1175 1185 10.1016/j.neurobiolaging.2003.12.009 15312963
27. Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice. C Priller G Mitteregger S Paluch N Vassallo M Staufenbiel HA Kretzschmar M Jucker J Herms, Neurobiology of aging 2009 30 8 1227 1237 10.1016/j.neurobiolaging.2007.10.016 18077058
28. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. D Moechars I Dewachter K Lorent D Reverse V Baekelandt A Naidu I Tesseur K Spittaels CV Haute F Checler, et al. JBiolChem 1999 274 10 6483 6492 (Pubitemid 29111064)
29. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. JS Jacobsen CC Wu JM Redwine TA Comery R Arias M Bowlby R Martone JH Morrison MN Pangalos PH Reinhart, et al. Proceedings of the National Academy of Sciences of the United States of America 2006 103 13 5161 5166 10.1073/pnas.0600948103 16549764
30. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. D Games D Adams R Alessandrini R Barbour P Berthelette C Blackwell T Carr J Clemens T Donaldson F Gillespie, Nature 1995 373 6514 523 527 10.1038/373523a0 7845465
31. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. AY Hsia E Masliah L McConlogue GQ Yu G Tatsuno K Hu D Kholodenko RC Malenka RA Nicoll L Mucke, ProcNatlAcadSciUSA 1999 96 6 3228 3233
32. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. J Larson G Lynch D Games P Seubert, Brain Res 1999 840 1-2 23 35 10.1016/S0006-8993(99)01698-4 10517949
33. Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine. SH Zaman A Parent A Laskey MK Lee DR Borchelt SS Sisodia R Malinow, NeurobiolDis 2000 7 1 54 63 10.1006/nbdi.1999.0271 (Pubitemid 30141819)
34. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1. RA Morton FM Kuenzi SM Fitzjohn TW Rosahl D Smith H Zheng M Shearman GL Collingridge GR Seabrook, NeurosciLett 2002 319 1 37 40
35. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. H Yu CA Saura SY Choi LD Sun X Yang M Handler T Kawarabayashi L Younkin B Fedeles MA Wilson, et al. Neuron 2001 31 5 713 726 10.1016/S0896-6273(01)00417-2 11567612
36. Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice. I Gureviciene S Ikonen K Gurevicius A Sarkaki T van Groen R Pussinen A Ylinen H Tanila, Neurobiology of disease 2004 15 2 188 195 10.1016/j.nbd.2003. 11.011 15006688
37. Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. A Gruart JC Lopez-Ramos MD Munoz JM Delgado-Garcia, Neurobiology of disease 2008 30 3 439 450 10.1016/j.nbd.2008.03.001 18442916
38. Aged wild-type littermates and APPswe+PS1/E9 mice present similar deficits in associative learning and spatial memory independent of amyloid load. SW Park HG Ko N Lee HR Lee YS Rim H Kim K Lee BK Kaang, Genes & Genomics 2010 32 63 70
39. Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice. S Gengler A Hamilton C Holscher, PLoS ONE 5 3 9764 10.1371/journal.pone.0009764 20339537
40. Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease. S Middei A Roberto N Berretta MB Panico S Lista G Bernardi NB Mercuri M Ammassari-Teule R Nistico, Learning & memory (Cold Spring Harbor, NY 2010 17 5 236 240
41. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. RB Knowles C Wyart SV Buldyrev L Cruz B Urbanc ME Hasselmo HE Stanley BT Hyman, Proceedings of the National Academy of Sciences of the United States of America 1999 96 9 5274 5279 10.1073/pnas.96.9.5274 10220456
42. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. AL Phinney T Deller M Stalder ME Calhoun M Frotscher B Sommer M Staufenbiel M Jucker, J Neurosci 1999 19 19 8552 8559 10493755
43. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. T Arendt, Neuroscience 2001 102 4 723 765 10.1016/S0306-4522(00)00516-9 11182240
44. The physiological regulation of synaptic inhibition by GABAB autoreceptors in rat hippocampus. CH Davies GL Collingridge, Journal of Physiology 1993 472 245 265 8145143
45. Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices. SM Fitzjohn RA Morton F Kuenzi CH Davies GR Seabrook GL Collingridge, Neuroscience letters 2000 288 1 9 12 10.1016/S0304-3940(00)01204-0 10869803
46. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. DM Walsh I Klyubin JV Fadeeva WK Cullen R Anwyl MS Wolfe MJ Rowan DJ Selkoe, Nature 2002 416 6880 535 539 10.1038/416535a 11932745
47. A specific amyloid-beta protein assembly in the brain impairs memory. S Lesne MT Koh L Kotilinek R Kayed CG Glabe A Yang M Gallagher KH Ashe, Nature 2006 440 7082 352 357 10.1038/nature04533 16541076
48. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. GM Shankar BL Bloodgood M Townsend DM Walsh DJ Selkoe BL Sabatini, J Neurosci 2007 27 11 2866 2875 10.1523/JNEUROSCI.4970-06.2007 17360908
49. Solution state characterization of amyloid beta-derived diffusible ligands. RW Hepler KM Grimm DD Nahas R Breese EC Dodson P Acton PM Keller M Yeager H Wang P Shughrue, et al. Biochemistry 2006 45 51 15157 15167 10.1021/bi061850f 17176037
50. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. RD Terry E Masliah DP Salmon N Butters R DeTeresa R Hill LA Hansen R Katzman, Annals of neurology 1991 30 4 572 580 10.1002/ana.410300410 1789684
51. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Y Goodman MP Mattson, Experimental neurology 1994 128 1 1 12 10.1006/exnr.1994.1107 8070512
52. Beyond amyloid: the next generation of Alzheimer's disease therapeutics. GR Seabrook WJ Ray M Shearman M Hutton, Mol Interv 2007 7 5 261 270 10.1124/mi.7.5.8 17932415
53. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. ED Roberson K Scearce-Levie JJ Palop F Yan IH Cheng T Wu H Gerstein GQ Yu L Mucke, Science (New York, NY) 2007 316 5825 750 754
54. Mechanisms of memory loss in Abeta and tau mouse models. KH Ashe, Biochem Soc Trans 2005 33 Pt 4 591 594 16042551
55. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. S Oddo A Caccamo JD Shepherd MP Murphy TE Golde R Kayed R Metherate MP Mattson Y Akbari FM LaFerla, Neuron 2003 39 3 409 421 10.1016/S0896-6273(03)00434-3 12895417